Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Wild D, Ell P, Perren A, Bomanji J, Weber W, Seufert J, Brändle M, Forrer F, Kurzawinski T, Caplin M, Christ E, Reubi J. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-8.
Jun 16, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Jun 16, 2011
J Nucl Med 2011; 52:1073-8
Wild Damian, Ell Peter J, Perren Aurel, Bomanji Jamshed, Weber Wolfgang A, Seufert Jochen, Brändle Michael, Forrer Flavio, Kurzawinski Tom R, Caplin Martyn E, Christ Emanuel, Reubi Jean Claude
more
